Deborah Weitzman's Insider Trades & SAST Disclosures

Deborah Weitzman's most recent trade in Cardinal Health, Inc. was a trade of 632 Common Shares done at an average price of $122.2 . Disclosure was reported to the exchange on Dec. 2, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Cardinal Health, Inc.
Deborah Weitzman CEO, PSS Segment Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.24 per share. 02 Dec 2024 632 49,129 (0%) 0% 122.2 77,256 Common Shares
Cardinal Health, Inc.
Deborah Weitzman CEO, PSS Segment Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Aug 2024 13,530 52,102 (0%) 0% 0 Common Shares
Cardinal Health, Inc.
Deborah Weitzman CEO, PSS Segment Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.36 per share. 15 Aug 2024 9,918 38,572 (0%) 0% 106.4 1,054,878 Common Shares
Cardinal Health, Inc.
Deborah Weitzman CEO, PSS Segment Payment of exercise price or tax liability using portion of securities received from the company at price $ 107.91 per share. 15 Aug 2024 2,341 49,761 (0%) 0% 107.9 252,617 Common Shares
Cardinal Health, Inc.
Deborah Weitzman CEO, PSS Segment Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Aug 2024 13,926 48,490 (0%) 0% 0 Common Shares
Cardinal Health, Inc.
Deborah Weitzman CEO, Pharmaceutical Segment Payment of exercise price or tax liability using portion of securities received from the company at price $ 107.08 per share. 01 Dec 2023 638 34,564 (0%) 0% 107.1 68,317 Common Shares
Cardinal Health, Inc.
Deborah Weitzman CEO, Pharmaceutical Segment Sale of securities on an exchange or to another person at price $ 106.31 per share. 27 Nov 2023 36,642 35,202 (0%) 0% 106.3 3,895,411 Common Shares
Cardinal Health, Inc.
Deborah Weitzman CEO, Pharmaceutical Segment Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.43 per share. 27 Nov 2023 15,373 71,844 (0%) 0% 66.4 1,021,228 Common Shares
Cardinal Health, Inc.
Deborah Weitzman CEO, Pharmaceutical Segment Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Nov 2023 15,373 0 - - Employee Stock Option (right to buy)
Cardinal Health, Inc.
Deborah Weitzman CEO, Pharmaceutical Segment Exercise or conversion of derivative security received from the company (such as an option) at price $ 83.19 per share. 27 Nov 2023 6,279 56,471 (0%) 0% 83.2 522,350 Common Shares
Cardinal Health, Inc.
Deborah Weitzman CEO, Pharmaceutical Segment Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Nov 2023 6,279 0 - - Employee Stock Option (right to buy)
Cardinal Health, Inc.
Deborah Weitzman CEO, Pharmaceutical Segment Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.27 per share. 27 Nov 2023 5,990 50,192 (0%) 0% 84.3 504,777 Common Shares
Cardinal Health, Inc.
Deborah Weitzman CEO, Pharmaceutical Segment Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Nov 2023 5,990 0 - - Employee Stock Option (right to buy)
Cardinal Health, Inc.
Deborah Weitzman CEO, Pharmaceutical Segment Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.43 per share. 28 Aug 2023 6,712 50,914 (0%) 0% 71.4 479,438 Common Shares
Cardinal Health, Inc.
Deborah Weitzman CEO, Pharmaceutical Segment Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Aug 2023 6,712 0 - - Employee Stock Option (right to buy)
Cardinal Health, Inc.
Deborah Weitzman CEO, Pharmaceutical Segment Sale of securities on an exchange or to another person at price $ 89.81 per share. 28 Aug 2023 6,712 44,202 (0%) 0% 89.8 602,805 Common Shares
Cardinal Health, Inc.
Deborah Weitzman CEO, Pharmaceutical Segment Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Aug 2023 15,487 44,202 (0%) 0% 0 Common Shares
Cardinal Health, Inc.
Deborah Weitzman CEO, Pharmaceutical Segment Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.99 per share. 15 Aug 2023 10,966 28,715 (0%) 0% 93.0 1,019,728 Common Shares
Cardinal Health, Inc.
Deborah Weitzman CEO, Pharmaceutical Segment Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Aug 2023 12,760 39,681 (0%) 0% 0 Common Shares
Cardinal Health, Inc.
Deborah Weitzman CEO, Pharmaceutical Segment Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.17 per share. 01 Dec 2022 380 26,921 (0%) 0% 80.2 30,465 Common Shares
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades